| Similar Articles |
|---|
 |
Chemistry World
April 6, 2009
Rebecca Trager |
US funding boost - a threat to EU science? These developments have raised some concern about the possibility of a 'brain drain' from Europe to the US, as these falling barriers have quickly made the region a more appealing destination for researchers.   |
Pharmaceutical Executive
October 1, 2012
Ben Comer |
Stem Cells: A Promise Deferred? Ideology, politics, and a stilted political debate may be causing pharma to overlook the potential of emerging stem cell therapies in fostering a new generation of cures. |
Bio-IT World
August 2005
Maureen McDonough |
U.K. Framework Offers Stem Cells a Future The United Kingdom has managed to cut through the noise surrounding stem cell research, creating a regulatory framework that fosters an environment of international collaboration and excellent R&D programs. And they try to do it all in an ethical way. |
Inc.
February 2005
Patrick J. Sauer |
The State of Stem Cell Research Californians are hoping that stem cell research will do for them what the invention of the car did for Michigan. |
HHMI Bulletin
Aug 2010
Lawrence Goldstein |
Hear from the author of "Stem Cells for Dummies" The author, an investigator at the University of California, San Diego, is reaching out beyond policymakers in an unorthodox way. He's co-written Stem Cells for Dummies. |
The Motley Fool
September 29, 2010
Brian Orelli |
Careful What You Wish For, Stem Cell Investors Investors seem to have forgotten about fundamentals. |
The Motley Fool
May 2, 2011
Brian Orelli |
StemCells Up for All the Right Reasons Federal funding doesn't matter for most stem cell companies. |
Salon.com
December 29, 2000
Arthur Allen |
Will Thompson, Bush clash over human embryo research? The HHS nominee supports it, but right-to-lifers want it stopped.... |
BusinessWeek
January 10, 2005
Bruce Einhorn |
Asia Is Stem Cell Central Singapore isn't the only country in the region trying to profit from the U.S. restrictions. Australia, China, India, Japan, and South Korea all see stem cell research as a way to get ahead in biotech. |
Salon.com
August 21, 2000
Lori B. Andrews |
Embryos under the knife The latest reproductive technology is just the next step on our sprint toward human cloning. |
HBS Working Knowledge
January 5, 2011 |
Funding Unpredictability Around Stem-Cell Research Inflicts Heavy Cost on Scientific Progress Society pays a high price for randomization of research support -- a fact that, sadly, is not recognized by the public, the media, or politicians. |
Bio-IT World
April 16, 2004
Kevin Davies |
A Black Eye for Bioethics Elizabeth Blackburn, an internationally renowned cell biologist, received a surprise phone call from the White House, informing her that her services on the President's Council on Bioethics would no longer be required. |
BusinessWeek
July 18, 2005
Moon Ihlwan |
Stem Cell Sleuth Seoul is funding Hwang Woo Suk in a bid to turn Korea into a global research hub for stem cell research. |
Wired
June 2005
Clive Thompson |
How to Farm Stem Cells Without Losing Your Soul A solution to the stem cell dilemma that even the Vatican can love. |
IEEE Spectrum
September 2006
Michael Dumiak |
Cells on Ice An engineering team prepares for the day when stem cells win public acceptance. |
Bio-IT World
October 14, 2004 |
Stem Cells and the Ballot Box Science policy is seldom a pivotal factor in U.S. presidential elections, but this year might be an exception. |
Wired
January 2003
Charles C. Mann |
The First Cloning Superpower Inside China's race to become the clone capital of the world. |
Wired
January 2004
Wendy Goldman Rohm |
Seven Days of Creation The inside story of a human cloning experiment |
Bio-IT World
July 15, 2003
Kevin Davies |
Stem Cell Suicide The International Society for Stem Cell Research must engage in a political discourse to salvage the hope of embryonic stem cell research. |
The Motley Fool
December 1, 2008
Brian Orelli |
Obama Can't Save Stem Cell Companies While government-sponsored research on embryonic stem cells might eventually help scientists better understand all stem cells, it's not likely to help the companies right now. |
The Motley Fool
February 2, 2005
Rich Duprey |
Aastrom to Leap Into Trials The biotech firm advances to the next stage of clinical studies in stem cell research. Investors, take note. |
HHMI Bulletin
May 2010 |
A Kaleidoscopic View Elaine Fuchs, head of the Laboratory of Mammalian Cell Biology and Development at Rockefeller University in New York, has managed to pioneer new ways of studying skin and hair and to manipulate stem cell differentiation. |
Scientific American
December 2008
Tim Hornyak |
Turning Back the Cellular Clock: A Farewell to Embryonic Stem Cells? Shinya Yamanaka discovered how to revert adult cells to an embryonic state. These induced pluripotent stem cells might soon supplant their embryonic cousins in therapeutic promise |
Scientific American
March 2006
Sara Beardsley |
Down in Flames Can stem cell research recover from Woo Suk Hwang? |
BusinessWeek
September 23, 2010
Rob Waters |
Stem Cells That Save Big Pharma a Bundle Drugmakers hope to save big by using stem cells to test drugs for dangerous side effects long before costly human trials are needed. |
The Motley Fool
November 9, 2004
Charly Travers |
Are Stem Cells a Rule Breaker? Does the science offer real hope or just hype? Biotech investors take on enough risk in the normal course of drug development that they do not need to worry about whether or not the underlying technology even works. |
